Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Neurovascular Devices Global Forecast Report 2025: A $7.22 Billion Opportunity by 2030, Driven by Advancement of AI- and Robot-Assisted Systems for Next-Generation Neurointerventions

globenewswire.com
SYK Stryker is mentioned as a key market player in the growing neurovascular devices market, which is expected to reach $7.22 billion by 2030. The article highlights advancements in AI- and robot-assisted systems as a driver for this market. MDT Medtronic is identified as a key market player in the neurovascular devices sector. The market is experiencing growth driven by technological advancements and increasing prevalence of neurovascular diseases, with a projected market size of $7.22 billion by 2030. JNJ Johnson & Johnson is listed as a key participant in the neurovascular devices market. The market is expected to grow significantly, driven by factors like aging populations and technological innovations in AI- and robot-assisted systems. TER Terumo Corporation is named as a key player in the neurovascular devices market, which is projected to grow to $7.22 billion by 2030. The growth is fueled by increasing neurovascular diseases and advancements in AI- and robot-assisted technologies. PEN Penumbra is mentioned as a key market player in the neurovascular devices industry. The market is experiencing robust growth, expected to reach $7.22 billion by 2030, with AI and robotic systems being significant drivers.

Neurovascular Devices Global Forecast Report 2025: A $7.22 Billion Opportunity by 2030, Driven by Advancement of AI- and Robot-Assisted Systems for Next-Generation Neurointerventions Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market by Disease Pathology, End User - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.

The global neurovascular devices market is poised for impressive growth, projected to climb from USD 4.64 billion in 2025 to USD 7.22 billion by 2030, at a CAGR of 9.3%.

This surge is primarily driven by the increasing prevalence of neurovascular diseases spurred by factors such as aging populations, hypertension, and sedentary lifestyles. This trend fuels the demand for advanced monitoring and treatment tools as conditions like stroke, brain aneurysms, and arteriovenous malformations become more common. An expanding elderly demographic, particularly vulnerable to these conditions, further accelerates the market demand. Continuous technological advancements enhance device efficiency and accuracy, appealing to healthcare providers and patients alike.

The report categorizes industry participants by company type, designation, and regional distribution, offering insights into the competitive landscape. Key market players include Stryker, Medtronic, Johnson & Johnson, Terumo Corporation, and Penumbra, among others, showcasing diverse innovations and strategic expansions.

Market Challenges and Opportunities

Despite promising growth prospects, the market grapples with challenges such as high treatment costs, a lack of skilled neurosurgeons, and stringent regulatory hurdles. Nonetheless, the market's potential remains strong, especially in precision-enhancing AI and robotic-assisted systems poised to revolutionize neurointerventions.

Cerebral Aneurysm Segment Dominates Disease Pathology

In the disease pathology segment, cerebral aneurysms hold the largest share of the global market. The prevalence of cerebral aneurysms is attributed to lifestyle factors, including smoking, chronic hypertension, and obesity, compounded by genetic predispositions. While middle-aged individuals and women are more susceptible, those with family histories of aneurysms face heightened risks, underscoring the segment's dominance.

Hospitals & Ambulatory Surgical Centers: Leading End Users

Among end users, hospitals and ambulatory surgical centers lead the market. Equipped with state-of-the-art diagnostic tools and skilled teams, these institutions manage critical conditions like strokes and aneurysms effectively. Their comprehensive care spectrum-from diagnostics to rehabilitation-ensures superior patient outcomes, explaining their market leadership.

Asia Pacific: A High-Growth Region

The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period. A rapid escalation in neurovascular disease cases coupled with rising demand for advanced treatments propels this market. Major industry players are establishing a stronger APAC presence by advancing technologies and refining robotic systems to tackle complex neurovascular conditions, presenting vast opportunities for growth.

Industry Participants and Competitive Landscape

Key Insights Include:

Key Attributes:

Market Dynamics

Drivers

Challenges

Opportunities

Company Profiles

Key Players

Other Key Players

SMEs/Startups

For more information about this report visit https://www.researchandmarkets.com/r/h7048a

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment